Qlucore Partners with Commugene in South Korean
News Sep 19, 2014
As the world’s 12th largest economy, South Korea is one of the fastest growing and most exciting markets in the world. The recent EU-South Korea Free Trade Agreement (FTA) has resulted in the vast majority of tariffs being removed, and initiatives by the Korean Government such as Bio-Vision 2016 to step up competitiveness and improve infrastructure, has created opportunities for business.
The biotech industry is one of the fastest growing industries in Korea with an annual growth rate of 10%. South Korean publicly listed bioscience companies in 2013 registered combined revenue of $8.3 billion. Clinical trials are becoming more commonplace locally, but there is a strong demand for international partnerships to conform to global standards.
Keeping abreast with these developments, and eager to capitalize on opportunities by a global approach, Qlucore, a world leader in the development of bioinformatics software, has appointed a new agent in South Korea, Commugene.
Through the partnership with Commugene, researchers in the biotechnology industry will have easier access to Qlucore's highly intuitive software, Qlucore Omics Explorer. This data analysis tool, both extremely powerful and yet easy to use, will be invaluable for unveiling important new discoveries.
"We are delighted to be entering into this agreement with Commugene, as we are confident that this cooperation will help researchers in South Korea to learn more about our software, and to achieve extraordinary results with their data analysis." commented Carl-Johan Ivarsson, President, Qlucore.
Qlucore Omics Explorer is unique in that it allows the actual researchers - the people with the most biological insight - to study their own data and to look for patterns and structures. As a result, researchers do not need to be statistics or computer experts in order to use Qlucore Omics Explorer effectively.
"We have no doubt that Qlucore Omics Explorer will be very attractive to the scientific community in South Korea," commented Jeong-hun Kim, Director of Marketing &Sales of Commugene on the new partnership.
Kim continued, “The biotech and pharmaceutical sectors in South Korea are growing very quickly, which means that there is a strong demand for truly innovative solutions in these areas. We therefore expect to promote Qlucore’s software with great success.”
Gene Therapy Could End Transfusions for Blood Disorder PatientsNews
Beta-thalassemia patients need a regular dose of red blood cells transfused into their body. A new gene therapy that edits faulty genes in the patients' cells could end this monthly ritual.READ MORE
How Do Plants Avoid UV Damage?News
Public health warnings against too much exposure to UV are based on sound advice: UV rays can damage DNA and cause cancers and other diseases. Plants, however, cannot avoid UV. A new study now shows how plants' DNA repair system helps combat constant UV exposure.READ MORE
Comments | 0 ADD COMMENT
International Conference on Epigenetics and Epitranscriptomics
Sep 17 - Sep 18, 2018